Symbol="CAPR"
AssetType="Common Stock"
Name="Capricor Therapeutics Inc"
Description="Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California."
CIK="1133869"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="114978000"
EBITDA="-29379816"
PERatio="None"
PEGRatio="0"
BookValue="0.246"
DividendPerShare="0"
DividendYield="0"
EPS="-1.19"
RevenuePerShareTTM="0.223"
ProfitMargin="0"
OperatingMarginTTM="-5.43"
ReturnOnAssetsTTM="-0.316"
ReturnOnEquityTTM="-1.878"
RevenueTTM="5538200"
GrossProfitTTM="1746400"
DilutedEPSTTM="-1.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="6.5"
EVToRevenue="35.42"
EVToEBITDA="-2.043"
Beta="3.993"
num_52WeekHigh="6.58"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.574"
num_200DayMovingAverage="4.482"
SharesOutstanding="25269900"
DividendDate="2019-06-05"
ExDividendDate="None"
symbol="CAPR"
open="4.53"
high="4.62"
low="4.46"
price="4.55"
volume="28491.00"
latest_trading_day="2023-07-21"
previous_close="4.46"
change="0.09"
change_percent="2.0179%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="73948"
Change_recent_avg="-0.01"
Delta_recent_avg="0.21"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="1114"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0147.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="953"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
